Birdwatch Note
2024-11-09 00:59:43 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
https://newsroom.csl.com/2024-09-13-Japans-Ministry-of-Health,-Labor-and-Welfare-Approves-CSL-and-Arcturus-Therapeutics-Updated-Self-amplifying-mRNA-COVID-19-Vaccine-for-Protection-against-JN-1-Strain,-to-be-Distributed-in-Japan-by-Meiji-Seika-Pharma This is the actual decision
Written by 5810E259144F5A421F8CF5A41C43DADE7C63EB1BC58FD27B8008BBE9576340CF
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1854509133254287524
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1855052616675606547
- noteId - 1855052616675606547
- participantId -
- noteAuthorParticipantId - 5810E259144F5A421F8CF5A41C43DADE7C63EB1BC58FD27B8008BBE9576340CF
- createdAtMillis - 1731113983684
- tweetId - 1854509133254287524
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- https://newsroom.csl.com/2024-09-13-Japans-Ministry-of-Health,-Labor-and-Welfare-Approves-CSL-and-Arcturus-Therapeutics-Updated-Self-amplifying-mRNA-COVID-19-Vaccine-for-Protection-against-JN-1-Strain,-to-be-Distributed-in-Japan-by-Meiji-Seika-Pharma This is the actual decision
Note Ratings
| rated at | rated by | |
| 2024-11-10 18:18:56 -0600 | Rating Details | |
| 2024-11-10 17:27:33 -0600 | Rating Details | |
| 2024-11-10 14:27:34 -0600 | Rating Details | |
| 2024-11-10 14:05:35 -0600 | Rating Details | |
| 2024-11-10 14:04:17 -0600 | Rating Details | |
| 2024-11-10 10:02:16 -0600 | Rating Details | |
| 2024-11-10 09:01:49 -0600 | Rating Details | |
| 2024-11-09 02:48:56 -0600 | Rating Details | |
| 2024-11-09 02:21:56 -0600 | Rating Details | |
| 2024-11-09 02:01:01 -0600 | Rating Details | |
| 2024-11-08 23:14:09 -0600 | Rating Details | |
| 2024-11-12 07:21:02 -0600 | Rating Details | |
| 2024-11-11 09:48:48 -0600 | Rating Details | |
| 2024-11-10 23:24:55 -0600 | Rating Details | |
| 2024-11-10 15:31:21 -0600 | Rating Details | |
| 2024-11-10 13:56:40 -0600 | Rating Details | |
| 2024-11-10 13:52:36 -0600 | Rating Details | |
| 2024-11-09 14:19:52 -0600 | Rating Details | |
| 2024-11-11 14:24:14 -0600 | Rating Details | |
| 2024-11-11 05:43:03 -0600 | Rating Details | |
| 2024-11-16 16:59:19 -0600 | Rating Details |